Table 3. The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between control subjects and patients with moyamoya disease.

Characteristics	Controls (n = 243, %)	Moyamoya patients (n = 107, %)	AOR (95% CI)	P *
KDR −604T>C
TT	113 (46.5)	47 (43.9)	1.000 (reference)
TC	108 (44.4)	50 (46.7)	1.131 (0.698–1.833)	0.617
CC	22 (9.1)	10 (9.3)	1.102 (0.482–2.517)	0.818
Dominant (CC vs. CA+AA)			1.128 (0.710–1.792)	0.609
Recessive (CC+CA vs. AA)			1.039 (0.470–2.296)	0.925
KDR 1192G>A
GG	186 (76.5)	80 (74.8)	1.000 (reference)
GA	52 (21.4)	22 (20.6)	0.994 (0.563–1.754)	0.983
AA	5 (2.1)	5 (4.7)	2.140 (0.596–7.693)	0.244
Dominant (GG vs. GA+AA)			1.101 (0.646–1.875)	0.725
Recessive (GG+GA vs. AA)			2.139 (0.597–7.665)	0.243
KDR 1719T>A
TT	46 (18.9)	26 (24.3)	1.000 (reference)
TA	114 (46.9)	45 (42.1)	0.764 (0.417–1.401)	0.384
AA	83 (34.2)	36 (33.6)	0.799 (0.427–1.495)	0.482
Dominant (TT vs. TA+AA)			0.775 (0.446–1.346)	0.365
Recessive (TT+TA vs. AA)			0.997 (0.613–1.620)	0.989

^*Adjusted by age and gender. AOR, adjusted odds ratio. CI, confidence interval.